Evidence map›Paper›PMID 19756020›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2010

Measurement error analysis for the determination of dopamine D(2) receptor occupancy using the agonist radioligand [(11)C]MNPA.

Miho Shidahara, Hiroshi Ito, Tatsui Otsuka, Yoko Ikoma, Ryosuke Arakawa, Fumitoshi Kodaka, Chie Seki, Harumasa Takano, Hidehiko Takahashi, Federico E Turkheimer and 3 more

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miho ShidaharaBiophysics Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.
Hiroshi Ito
Tatsui Otsuka
Yoko Ikoma
Ryosuke Arakawa
Fumitoshi Kodaka
Chie Seki
Harumasa Takano
Hidehiko Takahashi
Federico E Turkheimer
Yuichi Kimura
Iwao Kanno
Tetsuya Suhara

Funding

Medical Research Council MC_U120085814
6 · The paper itself

Abstract

The purpose of this study is to investigate errors in quantitative analysis for estimating dopamine D(2) receptor occupancy of antipsychotics with agonist radioligand [(11)C]MNPA by numerical simulation, with particular attention to the validity of a quantitative approach based on the use of a reference region. Synthetic data were validated using clinical data combined with a bootstrap approach. Time-activity curves (TACs) of [(11)C]MNPA were simulated, and the reliability of binding potential (BP(ND)) and occupancy estimated by nonlinear least square (NLS) fitting and a simplified reference tissue model (SRTM) were investigated for various noise levels and scan durations. In the human positron emission tomography (PET) study with and without antipsychotic, risperidone, the uncertainty of BP(ND) and occupancy estimated by SRTM was investigated using resampled TACs based on bootstrap approach with weighted residual errors of fitting. For both NLS and SRTM, it was possible to have <3% of bias in occupancy estimates of [(11)C]MNPA by 60 mins. However, shortened scan duration degrades the quantification of very small binding potentials, especially in case of SRTM. Observations were replicated on the clinical data. Results showed that dopamine D(2) receptor occupancy by antipsychotics can be estimated precisely in region of interest analysis by SRTM with a longer than 60-min [(11)C]MNPA PET scan duration.

Indexed as

RadiopharmaceuticalsAlgorithmsAntipsychotic AgentsApomorphineCerebellumComputer SimulationData Interpretation, StatisticalHumansKineticsLeast-Squares AnalysisMaleModels, StatisticalPositron-Emission TomographyReceptors, Dopamine D2RisperidoneYoung AdultAntipsychotic AgentsApomorphineN-n-propylnorapomorphineRadiopharmaceuticalsReceptors, Dopamine D2Risperidone

Identifiers

PMID19756020
PMCPMC2949103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.